MCP
ZYME icon

Maso Capital Partners’s Zymeworks ZYME Stock Holding History

Maso Capital Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-94,720
Closed -$1.55M – 56
2021
Q4 		$1.55M Hold
94,720
– – 0.71% 30
2021
Q3 		$2.75M Buy
+94,720
New +$3.15M 1.24% 15

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Maso Capital Partners's ZYME Position: Q1 2022 in Review

Maso Capital Partners sold out of Zymeworks (ZYME) in Q1 2022, closing a stake of 94,720 shares — an estimated $1.55M sold.

Maso Capital Partners first reported a position in ZYME in Q3 2021 and held it in 2 quarters. The position peaked at $2.75M in Q3 2021. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

  • Maso Capital Partners reported no remaining Zymeworks position as of Q1 2022 after selling out during the quarter.
  • Maso Capital Partners sold 94,720 Zymeworks shares in Q1 2022, an estimated $1.55M.
  • Maso Capital Partners first reported a position in Zymeworks in Q3 2021 and held it in 2 quarters.
  • Maso Capital Partners's Zymeworks position peaked at $2.75M in Q3 2021.
  • 120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on Maso Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.